During the COVID pandemic, RSV showed a slightly odd pattern: like flu, it basically disappeared in the 2020–2021 season, ...

Two new studies, one based on households in southeast Michigan and one involving hospitalized Japanese adults, compare ...

For the week ending Jan. 25, seasonal flu activity remains high and increasing. Clinical laboratories tested 129,378 ...

Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

Vulnerable and elderly Australians are missing out on protection against respiratory syncytial virus (RSV) because many can’t afford to pay $350 for a one-off vaccine.

The study, published Jan. 20 in The Lancet Infectious Diseases, found the vaccine to be 78% effective against RSV infection, 79% effective against emergency department and urgent care visits and 80% ...

Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their use.

Weekly case counts for the two respiratory illnesses have spiked in Erie County since Christmas, rising from a few dozen each in late December to 268 RSV cases and 321 flu cases the week ending Jan.

Two RSV vaccines were approved for use in Australia ... At its November meeting the PBAC conditionally recommended Abrysvo for older adults, but advised that “economic inputs should be revised ...